Bajaj Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.96 M
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.17 Cr
- Revenue Growth -1.79%
- Profit Growth 351.29%
- Ebitda 183.99%
- Net Worth 21.77%
- Total Assets 22.50%
About Bajaj Lifesciences
Bajaj Lifesciences Private Limited (BLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 October 2005 and has a history of 19 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.96 M.
The company has closed loans amounting to ₹5.17 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aditi Bajaj and Santosh Bajaj serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231MH2005PTC157042
-
Company No.
157042
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Oct 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bajaj Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Bajaj
|
Director | 12-Mar-2019 | Current |
|
Santosh Bajaj
|
Director | 25-Apr-2024 | Current |
Financial Performance of Bajaj Lifesciences.
Bajaj Lifesciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.79% decrease. The company also saw a substantial improvement in profitability, with a 351.29% increase in profit. The company's net worth Soared by an impressive increase of 21.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bajaj Lifesciences?
In 2022, Bajaj Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Epstom Spec Chem Private LimitedSantosh Bajaj is a mutual person
Charges (Loans)
₹0
₹51.70 M
Charges Breakdown by Lending Institutions
- Others : 2.40 Cr
- The Saraswat Cooperative Bank Ltd : 2.10 Cr
- The Saraswat Co-Op Bank Ltd : 0.67 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Nov 2019 | Others | ₹2.40 Cr | Satisfied |
| 19 Oct 2011 | The Saraswat Cooperative Bank Ltd | ₹2.50 M | Satisfied |
| 12 Dec 2008 | The Saraswat Cooperative Bank Ltd | ₹5.00 M | Satisfied |
| 03 Jul 2008 | The Saraswat Co-Op Bank Ltd | ₹2.60 M | Satisfied |
| 20 Jun 2008 | The Saraswat Co-Op Bank Ltd | ₹1.90 M | Satisfied |
How Many Employees Work at Bajaj Lifesciences?
Unlock and access historical data on people associated with Bajaj Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bajaj Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bajaj Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
